Belgium· BE-AMP-SAM236056-00

BCG-Medac

A bcg-impfstoff product containing mycobacterium tuberculosi (= bcg) (= bacillus calmette-guerin), registered in Belgium by Medac. The same ATC class is registered in 11 of our 19 countries.

ATC L03AX03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedBCG-MedacATCL03AX03REGISTER NO.BE-AMP-SAM236056-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Bcg-impfstoff is registered in 11 of 19 countries.

Countries holding a registration under ATC L03AX03 (bcg-impfstoff), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Bcg-impfstoff · ATC L03AX03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Mycobacterium Tuberculosi (= Bcg) (= Bacillus Calmette-Guerin)
Manufacturer
Medac
Country
Belgium (BE)
ATC code
L03AX03
ATC class
BCG-Impfstoff
Defined daily dose
0.033 Darreichungsform, intravesikal
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2912483

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bcg-impfstoff in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bcg-impfstoff products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8930192d-7194-4dee-b407-a447313bf735
GET /v1/drugs/8930192d-7194-4dee-b407-a447313bf735?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for intravesical suspension",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "BCG-Medac",
  "name_fr": "BCG-Medac",
  "name_nl": "BCG-Medac",
  "amp_code": "SAM236056-00",
  "strengths": [
    "2.0000",
    "1080.0000",
    "0.5000"
  ],
  "pack_count": 6,
  "substances": [
    "Mycobacterium Tuberculosi (= Bcg) (= Bacillus Calmette-Guerin)",
    "Glucose",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Bcg Vaccine",
  "authorisation_numbers": [
    "BE236056"
  ]
}

See everything about bcg-impfstoff.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.